Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial TF was detectable in 75.4% of baseline ...

Testing for somatic genomic copy number alterations (CNAs) in ulcerative colitis patients with low-grade dysplasia was able to predict risk of advanced neoplasia more accurately than other currently ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study from researchers at Memorial Sloan Kettering Cancer ...